JEFFREY W SHERMAN
CIK 1230482 · EVP and Chief Medical Officer · last filed 2026-05-20
JEFFREY W SHERMAN is an EVP and Chief Medical Officer who has filed 82 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for LRMR, was dated May 20, 2026. Across all open-market trades the lifetime net is −$31.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.83M
5
82
-$31.15M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LRMR | Director | 5,000 | $3.47 | $17.4K | $25.0K | 5 | 2026-05-20 |
| XERS | Director | 266,820 | $6.79 | $1.81M | -$324.4K | 11 | 2025-08-29 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP and Chief Medical Officer | 0 | $116.30 | $0 | -$30.85M | 55 | 2023-10-06 |
| Strongbridge Biopharma plc (SBBP) Delisted | Director | 0 | $2.00 | $0 | $0 | 8 | 2021-10-06 |
| IDM PHARMA, INC. (IDMI) Delisted | Sr. VP, R & D and CMO | — | — | — | $0 | 2 | 2008-04-07 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | LRMR | Grant (A) | — | $0 | EDGAR |
| 2026-03-02 | LRMR | Buy (P) | +5,000 | $25.0K | EDGAR |
| 2025-08-29 | XERS | Mixed | +4,808 | -$21.2K | EDGAR |
| 2025-06-04 | XERS | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-05-14 | LRMR | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | XERS | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-05-31 | LRMR | Grant (A) | — | $0 | EDGAR |
| 2024-04-11 | XERS | Other (J) | +6,502 | $0 | EDGAR |
| 2023-11-29 | XERS | Buy (P) | +5,400 | $10.1K | EDGAR |
| 2023-10-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Disp (D) | −234,759 | -$27.35M | EDGAR |